Delivery Order SPE2DB24D2106-SPE2DB25FAWLV
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,162.08 to DMS Pharmaceutical Group Inc. for the supply of Jardiance 25 mg tablets (90-count packages). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform delivery to Conshohocken, Pennsylvania by the August 22, 2025 completion date. This delivery order was awarded without set-aside designation and represents a continuation of DMS...
- The U.S. Department of Defense's Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Jardiance 25 mg tablets. The order has a potential value of $4,094.64 and is set to be completed by February 9, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that holds an indefinite delivery contract with the Defense Logistics Agency, valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,631.11 to DMS Pharmaceutical Group Inc. for 90-count tablets of Jardiance 25 mg, an oral diabetes medication. This firm fixed-price delivery order was issued on October 29, 2025, with an ultimate completion date of October 30, 2025, and represents a routine pharmaceutical supply transaction issued without set-aside designation. The place of performance is Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a...
- The Defense Logistics Agency awarded a delivery order valued at $31,518.19 to DMS Pharmaceutical Group Inc. for 90 tablets of Jardiance 25 mg, a diabetes medication. The award was issued on August 18, 2025, with an ultimate completion date of August 19, 2025. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.9 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was awarded a firm fixed-price delivery order valued at $8,512.19 by the Defense Logistics Agency (DLA) on September 19, 2025, for the supply of Jardiance 25 mg tablets in quantities of 90. The delivery order, which carries no set-aside designation, is scheduled for completion by September 22, 2025, with performance to take place in Conshohocken, Pennsylvania. This award represents a discrete delivery order...
- This delivery order, valued at $3,723.43, was awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc. for the supply of Jardiance 25 mg tablets in quantities of 90 units. The award, executed on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a firm fixed-price contract with no set-aside designation. Performance of this order will occur at the vendor's facility in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of Jardiance 10 mg tablets. The contract has a potential value of $2,047.32 and a completion date of February 9, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that offers a comprehensive range of brand and generic prescription and...
- The Defense Logistics Agency awarded a delivery order valued at $4.7 million to DMS Pharmaceutical Group Inc. for 90-count tablets of Jardiance 25 mg, a diabetes medication. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. The contract utilizes a firm fixed-price structure with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $9,836.57 to DMS Pharmaceutical Group Inc. for 90 tablets of Jardiance 25 mg on October 28, 2025, with a completion date of October 29, 2025. This delivery order utilizes a firm fixed-price contract structure with no set-aside designation, indicating the award was made through unrestricted federal procurement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois,...
- The Defense Logistics Agency awarded a delivery order valued at $3,686.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jardiance 25 mg tablets (90-count units). The delivery order, issued on October 20, 2025, with an ultimate completion date of October 21, 2025, represents a firm fixed-price contract with no set-aside designation. Performance will be executed at the company's facility in Conshohocken,...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB25FAWLVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,772.99 to DMS Pharmaceutical Group Inc. for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price delivery order, issued on September 15, 2025, represents fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026. The contract carries no set-aside designation. Performance will be completed by September 16, 2025, with the product to be delivered to Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as the prime contractor on this award. The company maintains a substantial federal contract portfolio focused on supplying comprehensive pharmaceutical products to Department of Defense healthcare facilities nationwide, including branded and generic prescription medications, biologics, and medical consumables. The underlying SPE2DB indefinite delivery vehicle with DLA enables the agency to procure a broad range of pharmaceutical items to support medical supply needs across military health facilities globally, positioning DMS Pharmaceutical Group as a critical supplier within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 9/15/25 |